150 resultados para R5
Resumo:
Pós-graduação em Agronomia (Produção Vegetal) - FCAV
Resumo:
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
Resumo:
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
Resumo:
We report for the first time the genetic and biological characterization of 10 HIV-1 primary isolates representing CRF28_BF and CRF29_BF together with additional unique BF recombinant forms (URFs) obtained by PBMC cocultivation. Recombination is an important factor promoting the increase in the genetic diversity of HIV-1. Notably, more than 20% of HIV-1 sequences worldwide were recombinants. Several recombinant viruses were reported in Brazil, and six circulating recombinant forms (CRFs) have been identified (CRF28_BF, CRF29_BF, CRF31_BC, CRF39_BF, CRF40_BF, and CRF46_BF). CRF28_BF and CRF29_BF were found to infect almost 30% of the patients in Sao Paulo State. The near full-length genomes of these 10 primary isolates were amplified by nested PCR in three overlapping segments, purified, and sequenced. Three samples were related to CRF28_BF, three to CRF29_BF, and four were unique recombinant forms (URFs), as determined by their breakpoint profile determined with the jpHMM program. Additionally, the coreceptor usage of these isolates was investigated in vitro using GHOST assays, which revealed three dual-tropic (X4/R5) viruses, four lymphotropic (X4) viruses, and three macrophage-tropic (R5) viruses with different V3-loop motifs, which challenges the notion that GWGR-carrying viruses are macrophage-tropic only. In sum, we report a much-anticipated well-characterized panel of viruses representing CRF28_BF, CRF29_BF, and URFs from Sao Paulo State, Brazil.
Resumo:
While human immunodeficiency virus (HIV)-1 chemokine co-receptors 5 tropism and the GWGR motif in the envelope third variable region (V3 loop) have been associated with a slower disease progression, their influence on antiretroviral response remains unclear. The impact of baseline V3 characteristics on treatment response was evaluated in a randomised, double blind, prospective cohort study with patients initiating highly active antiretroviral therapy with lopinavir or efavirenz plus azithothymidine/3TC (1:1) over 48 weeks. Similar virological and immunological responses were observed for both treatment regimens. The 43 individuals had a mean baseline CD4 T cell count of 119 cells/mm(3) [standard deviation (SD) = 99] and a mean viral load of 5.09 log(10) copies/mL (SD = 0.49). The GWGR motif was not associated with a CD4 T cell response, but predicted R5 tropism by the geno2pheno([clinical20%]) algorithm correlated with higher CD4 T cell levels at all monitoring points (p < 0.05). Moreover, higher false-positive rates (FPR) values from this analysis revealed a strong correlation with CD4 T cell recovery (p < 0.0001). Transmitted drug resistance mutations, documented in 3/41 (7.3%) cases, were unrelated to the assigned antiretroviral regimen and had no impact on patient outcomes. In conclusion, naive HIV-1 R5 infected patients exhibited higher CD4 T cell counts at baseline; this difference was sustained throughout therapy. The geno2pheno[clinical] option FPR positively correlated with CD4 T cell gain and may be useful in predicting CD4 T cell recovery.
Resumo:
Introduction: Primary HIV infection is usually caused by R5 viruses, and there is an association between the emergence of CCXR4-utilizing strains and faster disease progression. We characterized HIV-1 from a cohort of recently infected individuals in Brazil, predicted the virus's co-receptor use based on the env genotype and attempted to correlate virus profiles with disease progression. Methods: A total of 72 recently infected HIV patients were recruited based on the Serologic Testing Algorithm for Recent HIV Seroconversion and were followed every three to four months for up to 78 weeks. The HIV-1 V3 region was characterized by sequencing nine to twelve weeks after enrollment. Disease progression was characterized by CD4+ T-cell count decline to levels consistently below 350 cells/mu L. Results: Twelve out of 72 individuals (17%) were predicted to harbor CXCR4-utilizing strains; a baseline CD4,350 was more frequent among these individuals (p = 0.03). Fifty-seven individuals that were predicted to have CCR5-utilizing viruses and 10 individuals having CXCR4-utilizing strains presented with baseline CD4.350; after 78 weeks, 33 individuals with CCR5 strains and one individual with CXCR4 strains had CD4.350 (p = 0.001). There was no association between CD4 decline and demographic characteristics or HIV-1 subtype. Conclusions: Our findings confirm the presence of strains with higher in vitro pathogenicity during early HIV infection, suggesting that even among recently infected individuals, rapid progression may be a consequence of the early emergence of CXCR4-utilizing strains. Characterizing the HIV-1 V3 region by sequencing may be useful in predicting disease progression and guiding treatment initiation decisions.
Resumo:
Background: The first stages of HIV-1 infection are essential to establish the diversity of virus population within host. It has been suggested that adaptation to host cells and antibody evasion are the leading forces driving HIV evolution at the initial stages of AIDS infection. In order to gain more insights on adaptive HIV-1 evolution, the genetic diversity was evaluated during the infection time in individuals contaminated by the same viral source in an epidemic cluster. Multiple sequences of V3 loop region of the HIV-1 were serially sampled from four individuals: comprising a single blood donor, two blood recipients, and another sexually infected by one of the blood recipients. The diversity of the viral population within each host was analyzed independently in distinct time points during HIV-1 infection. Results: Phylogenetic analysis identified multiple HIV-1 variants transmitted through blood transfusion but the establishing of new infections was initiated by a limited number of viruses. Positive selection (d(N)/d(S)>1) was detected in the viruses within each host in all time points. In the intra-host viruses of the blood donor and of one blood recipient, X4 variants appeared respectively in 1993 and 1989. In both patients X4 variants never reached high frequencies during infection time. The recipient, who X4 variants appeared, developed AIDS but kept narrow and constant immune response against HIV-1 during the infection time. Conclusion: Slowing rates of adaptive evolution and increasing diversity in HIV-1 are consequences of the CD4+ T cells depletion. The dynamic of R5 to X4 shift is not associated with the initial amplitude of humoral immune response or intensity of positive selection.
Resumo:
While human immunodeficiency virus (HIV)-1 chemokine co-receptors 5 tropism and the GWGR motif in the envelope third variable region (V3 loop) have been associated with a slower disease progression, their influence on antiretroviral response remains unclear. The impact of baseline V3 characteristics on treatment response was evaluated in a randomised, double blind, prospective cohort study with patients initiating highly active antiretroviral therapy with lopinavir or efavirenz plus azithothymidine/3TC (1:1) over 48 weeks. Similar virological and immunological responses were observed for both treatment regimens. The 43 individuals had a mean baseline CD4 T cell count of 119 cells/mm³ [standard deviation (SD) = 99] and a mean viral load of 5.09 log10 copies/mL (SD = 0.49). The GWGR motif was not associated with a CD4 T cell response, but predicted R5 tropism by the geno2pheno[clinical20%] algorithm correlated with higher CD4 T cell levels at all monitoring points (p < 0.05). Moreover, higher false-positive rates (FPR) values from this analysis revealed a strong correlation with CD4 T cell recovery (p < 0.0001). Transmitted drug resistance mutations, documented in 3/41 (7.3%) cases, were unrelated to the assigned antiretroviral regimen and had no impact on patient outcomes. In conclusion, naÏve HIV-1 R5 infected patients exhibited higher CD4 T cell counts at baseline; this difference was sustained throughout therapy. The geno2pheno[clinical] option FPR positively correlated with CD4 T cell gain and may be useful in predicting CD4 T cell recovery.
Resumo:
This study compared the effectiveness of the multifocal visual evoked cortical potentials (mfVEP) elicited by pattern pulse stimulation with that of pattern reversal in producing reliable responses (signal-to-noise ratio >1.359). Participants were 14 healthy subjects. Visual stimulation was obtained using a 60-sector dartboard display consisting of 6 concentric rings presented in either pulse or reversal mode. Each sector, consisting of 16 checks at 99% Michelson contrast and 80 cd/m² mean luminance, was controlled by a binary m-sequence in the time domain. The signal-to-noise ratio was generally larger in the pattern reversal than in the pattern pulse mode. The number of reliable responses was similar in the central sectors for the two stimulation modes. At the periphery, pattern reversal showed a larger number of reliable responses. Pattern pulse stimuli performed similarly to pattern reversal stimuli to generate reliable waveforms in R1 and R2. The advantage of using both protocols to study mfVEP responses is their complementarity: in some patients, reliable waveforms in specific sectors may be obtained with only one of the two methods. The joint analysis of pattern reversal and pattern pulse stimuli increased the rate of reliability for central sectors by 7.14% in R1, 5.35% in R2, 4.76% in R3, 3.57% in R4, 2.97% in R5, and 1.78% in R6. From R1 to R4 the reliability to generate mfVEPs was above 70% when using both protocols. Thus, for a very high reliability and thorough examination of visual performance, it is recommended to use both stimulation protocols.
Resumo:
I RAEE (Rifiuti da Apparecchiature Elettriche ed Elettroniche) costituiscono un problema prioritario a livello europeo per quanto riguarda la loro raccolta, stoccaggio, trattamento, recupero e smaltimento, essenzialmente per i seguenti tre motivi: Il primo riguarda le sostanze pericolose contenute nei RAEE. Tali sostanze, nel caso non siano trattate in modo opportuno, possono provocare danni alla salute dell’uomo e all’ambiente. Il secondo è relativo alla vertiginosa crescita relativa al volume di RAEE prodotti annualmente. La crescita è dovuta alla continua e inesorabile commercializzazione di prodotti elettronici nuovi (è sufficiente pensare alle televisioni, ai cellulari, ai computer, …) e con caratteristiche performanti sempre migliori oltre all’accorciamento del ciclo di vita di queste apparecchiature elettriche ed elettroniche (che sempre più spesso vengono sostituiti non a causa del loro malfunzionamento, ma per il limitato livello di performance garantito). Il terzo (ed ultimo) motivo è legato all’ambito economico in quanto, un corretto trattamento dei RAEE, può portare al recupero di materie prime secondarie (alluminio, ferro, acciaio, plastiche, …) da utilizzare per la realizzazione di nuove apparecchiature. Queste materie prime secondarie possono anche essere vendute generando profitti considerevoli in ragione del valore di mercato di esse che risulta essere in costante crescita. Questo meccanismo ha portato a sviluppare un vasto quadro normativo che regolamenta tutto l’ambito dei RAEE dalla raccolta fino al recupero di materiali o al loro smaltimento in discarica. È importante inoltre sottolineare come lo smaltimento in discarica sia da considerarsi come una sorta di ‘ultima spiaggia’, in quanto è una pratica piuttosto inquinante. Per soddisfare le richieste della direttiva l’obiettivo dev’essere quello di commercializzare prodotti che garantiscano un minor impatto ambientale concentrandosi sul processo produttivo, sull’utilizzo di materiali ‘environmentally friendly’ e sulla gestione consona del fine vita. La Direttiva a livello europeo (emanata nel 2002) ha imposto ai Paesi la raccolta differenziata dei RAEE e ha definito anche un obiettivo di raccolta per tutti i suoi Stati Membri, ovvero 4 kg di RAEE raccolti annualmente da ogni abitante. Come riportato di seguito diversi paesi hanno raggiunto l’obiettivo sopra menzionato (l’Italia vi è riuscita nel 2010), ma esistono anche casi di paesi che devono necessariamente migliorare il proprio sistema di raccolta e gestione dei RAEE. Più precisamente in Italia la gestione dei RAEE è regolamentata dal Decreto Legislativo 151/2005 discusso approfonditamente in seguito ed entrato in funzione a partire dal 1° Gennaio 2008. Il sistema italiano è basato sulla ‘multi consortilità’, ovvero esistono diversi Sistemi Collettivi che sono responsabili della gestione dei RAEE per conto dei produttori che aderiscono ad essi. Un altro punto chiave è la responsabilità dei produttori, che si devono impegnare a realizzare prodotti durevoli e che possano essere recuperati o riciclati facilmente. I produttori sono coordinati dal Centro di Coordinamento RAEE (CDC RAEE) che applica e fa rispettare le regole in modo da rendere uniforme la gestione dei RAEE su tutto il territorio italiano. Il documento che segue sarà strutturato in quattro parti. La prima parte è relativa all’inquadramento normativo della tematica dei RAEE sia a livello europeo (con l’analisi della direttiva ROHS 2 sulle sostanze pericolose contenute nei RAEE e la Direttiva RAEE), sia a livello italiano (con un’ampia discussione sul Decreto Legislativo 151/2005 e Accordi di Programma realizzati fra i soggetti coinvolti). La seconda parte tratta invece il sistema di gestione dei RAEE descrivendo tutte le fasi principali come la raccolta, il trasporto e raggruppamento, il trattamento preliminare, lo smontaggio, il riciclaggio e il recupero, il ricondizionamento, il reimpiego e la riparazione. La terza definisce una panoramica delle principali metodologie di smaltimento dei 5 raggruppamenti di RAEE (R1, R2, R3, R4, R5). La quarta ed ultima parte riporta i risultati a livello italiano, europeo ed extra-europeo nella raccolta dei RAEE, avvalendosi dei report annuali redatti dai principali sistemi di gestione dei vari paesi considerati.
Resumo:
Il progetto degli edifici privi di smorzatori viscosi eseguito adottando un fattore di riduzione delle forze R5 (fattore di struttura q del D.M.14/01/08) relativo ad uno smorzamento ξ = 5%, mentre per quelli equipaggiati con smorzatori viscosi il fattore di riduzione delle forze adottato sarà R30 = α R5 relativo ad uno smorzamento ξ = 30%, dove il parametro α è un valore tale da garantire un uguale o maggiore livello di sicurezza della struttura ed è assunto pari a 0,9 da analisi precedenti. Quello che in conclusione si vuole ottenere è che la richiesta di duttilità delle strutture con R30 e ξ = 30% sia minore o uguale di quella richiesta dalle strutture con R5 e ξ = 5%: μd30 ≤ μd5 Durante il percorso di tesi è stata anche valutata una procedura di definizione delle curve di Pushover manuale; la procedura indaga un modo rapido e concettualmente corretto per definire un ordine di grandezza della curva di capacità della struttura.
Resumo:
Der Haupt-Lichtsammelkomplex des Fotosystems II (LHCII) setzt sich aus einem Proteinanteil und nicht-kovalent gebundenen Pigmenten – 8 Chlorophyll a, 6 Chlorophyll b und 4 Carotinoide - zusammen. Er assembliert in vivo zu einem Trimer, in dem die Monomereinheiten ebenfalls nicht-kovalent miteinander wechselwirken. Die ausgesprochen hohe Farbstoffdichte und die Tatsache, dass der Komplex rekombinant hergestellt werden kann, machen den LHCII zu einem interessanten Kandidaten für technische Anwendungen wie einer Farbstoffsolarzelle. Allerdings muss hierzu seine thermische Stabilität drastisch erhöht werden.rnDer Einschluss von Proteinen/Enzymen in Silikat erhöht deren Stabilität gegenüber Hitze signifikant. LHCII sollte als erster rekombinanter Membranproteinkomplex mittels kovalent verbundener, polykationischen Sequenzen in Silikat eingeschlossen werden. Hierzu wurde der Komplex auf zwei Weisen polykationisch modifiziert: Auf Genebene wurde die Sequenz des R5-Peptids in den N-terminalen Bereich des LHCP-Gens eingeführt und ein Protokoll zur Überexpression, Rekonstitution und Trimerisierung etabliert. Außerdem wurde eine kovalente Modifikation des trimeren LHCII mit dem Arginin-reichen Protamin über heterobifunktionelle Crosslinker entwickelt. Beide resultierenden LHCII-Derivate waren in der Lage, Silikat autogen zu fällen. Die Stabilisierung der so in Silikat präzipitierten Komplexe war jedoch deutlich geringer als bei nicht-modifizierten Komplexen, die durch eine Spermin-induzierte Copräzipitation eingeschlossenen wurden. Dabei zeigte sich, dass für den Anteil der eingebauten Komplexe und das Ausmaß an Stabilisierung die Größe und klare partikuläre Struktur des Silikats entscheidend ist. Kleine Partikel mit einem Durchmesser von etwa 20 nm führten zu einem Einbau von rund 75 % der Komplexe, und mehr als 80 % des Energietransfers innerhalb des Komplexes blieben erhalten, wenn für 24 Stunden bei 50°C inkubiert wurde. Nicht in Silikat eingeschlossene Komplexe verloren bei 50°C ihren Komplex-internen Energietransfer binnen weniger Minuten. Es war dabei unerheblich, ob die Partikelgröße durch die Wahl des Puffers und des entsprechenden pH-Wertes, oder aber durch Variation des Spermin-zu-Kieselsäure-Verhältnisses erreicht wurde. Wurden die polykationisch veränderten Komplexe in solchen Copräzipitationen verwendet, so erhöhte sich der Anteil an eingebauten Komplexen auf über 90 %, jedoch wurde nur bei der R5-modifizierten Variante vergleichbare Ausmaße an Stabilisierung erreicht. Ein noch höherer Anteil an Komplexen wurde in das Silikatpellet eingebaut, wenn LHCII kovalent mit Silanolgruppen modifiziert wurde (95 %); jedoch war das Ausmaß der Stabilisierung wiederum geringer als bei einer Copräzipitation. Die analysierten Fällungssysteme waren außerdem in der Lage, Titandioxid zu fällen, wobei der Komplex in dieses eingebaut wurde. Allerdings muss das Stabilisierungspotential hier noch untersucht werden. Innerhalb eines Silikatpräzipitats aggregierten die Komplexe nicht, zeigten aber einen inter-trimeren Energietransfer, der sehr wahrscheinlich auf einem Förster Resonanz Mechanismus basiert. rnDies und das hohe Maß an Stabilisierung eröffnen neue Möglichkeiten, rekombinanten LHCII in technischen Applikationen als Lichtsammelkomponente zu verwenden.rn
Resumo:
unter der Red. von Wladimir Jabotinsky
Resumo:
von Rieger
Resumo:
von Paul Rieger